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Benign paroxysmal positional vertigo (BPPV) is a common form of vertigo and is charac-
terized by episodic dizziness related to changes in head position relative to gravity. BPPV
symptoms can be similar to those of central nervous system vascular diseases. The asso-
ciation between BPPV and ischemic stroke has not yet been investigated.The study cohort
consisted of patients who were diagnosed with BPPV at least twice in the previous year
as an outpatient or for whom BPPV was the primary diagnosis as an inpatient (n=4104).
An age- and gender-matched sample that excluded patients with a diagnosis of any form of
vertigo was selected as the comparison cohort (n=8397). All cases were followed up from
January 1, 2000, to December 31, 2008.The demographic characteristics, medical comor-
bidities, and use of medications in both groups were investigated using chi-square tests.
A stratified analysis of stroke risk factors was performed to determine the hazard ratios of
BPPV. During the 9-year follow-up period, 185 of the 4104 (4.5%) subjects with BPPV and
240 of the 8379 (2.9%) subjects without BPPV developed ischemic strokes.The crude haz-
ard ratio of BPPV for developing ischemic strokes was 1.708. After adjusting for stroke risk
factors, the risk of developing ischemic strokes in BPPV subjects was 1.415-fold higher than
the risk among those without BPPV (confidence interval: 1.162–1.732, p=0.001). After a
subgroup analysis stratified according to stroke risk factors, BPPV remained independently
associated with a higher risk of developing future ischemic stroke. We conclude that BPPV
is independently associated with a risk of subsequent ischemic stroke. More aggressive
control of modifiable risk factors for ischemic strokes should be conducted in patients with
BPPV.
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INTRODUCTION
Benign paroxysmal positional vertigo (BPPV), first described by
Barany, is characterized by brief episodes of vertiginous attacks
precipitated by changes in head positions relative to gravity
(Bárány, 1920). BPPV is one of the most common types of ver-
tigo and causes balance disorders in the aging population (Baloh,
1992). Abnormal stimulation of the cupula by calcium carbonate
debris within the semicircular canals has been proposed to cause
BPPV (Schuknecht, 1969; Hall et al., 1979). The diagnosis of the
canals involved in BPPV is based on the symptoms and directions
of nystagmus in the Hallpike–Dix test (Dix and Hallpike, 1952;
Furman and Cass, 1999).
The actual etiology of BPPV remains unclear. Advanced age,
head trauma, inactivity, viral labyrinthitis, and ischemia of the
anterior vestibular artery may predispose individuals to BPPV
(Baloh et al., 1987; Steenerson et al., 2005). Numerous investi-
gations have reported increased incidence in females and the aged
population (Lynn et al., 1995; Angeli et al., 2003;Yimtae et al., 2003;
Steenerson et al., 2005; Kao et al., 2009). Physical exercise, such
as the canalith repositioning maneuver, yields a 67–94% rate of
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successful remission (Susan and Herdman, 2007). Physical therapy
is the primary treatment after a BPPV diagnosis. Although benign
in nature, BPPV can be devastating during spells of attacks, causing
physical and psychological distress. Comorbid conditions, such as
anxiety, depression, and chronic dizziness, may be underestimated,
especially in female (Ferrari et al., 2014).
There are positional vertigo, which mimic BPPV, those include
migraine, tumor or stroke, cerebellar or brainstem disorders, per-
ilymphatic fistula, superior canal dehiscence, hypermobile stapes
(Susan and Herdman,2007). Some vestibular ischemic strokes may
be perceived as inner ear dysfunctions, such as hearing loss or ver-
tigo (Kim and Lee, 2009). In a previous study, 10.4% of patients
with cerebellar infarction only showed symptoms of vestibular
neuritis (Lee et al., 2006). Positional vertigo with central causes is
diagnosed in 12% of patients with positional vertigo (Bertholon
et al., 2006). Although central nervous lesions, such as ischemic
stroke, rarely present with recurrent or positional vertigo with-
out other neurological abnormalities (Watson et al., 1981; Estol
et al., 1996), BPPV patients in the clinic often enquire if they are
experiencing a stroke or if this condition could cause strokes later
in life.
The risk and occurrence of ischemic stroke in BPPV patients
have not been previously investigated. Therefore, this study aimed
to determine the risk of subsequent ischemic stroke in patients
with BPPV using a population-based study. This retrospective
cohort study may provide valuable information regarding demo-
graphic risk factors and comorbidities of BPPV and its association
with ischemic stroke in Taiwanese populations.
MATERIALS AND METHODS
DATABASE
The Taiwan National Health Research Institute (NHRI) database
was used for this study. This database contains original medical
data from one million individuals specifically selected by Taiwan’s
National Health Insurance (NHI). The NHI is the single largest
medical health insurance company in Taiwan and contains the
medical registry of all board-certified physicians and contracted
medical facilities. More than 98% of the Taiwanese population is
included in this program. The data from the NHI program are rep-
resentative of the general medical health status of the Taiwanese
population. According to Taiwan NHRI, there are no significant
differences in age, gender, or health care costs between the sampled
patients in the database and all the beneficiaries of the NHI pro-
gram. Thus, this database is a valuable source for investigating the
relationship between the incidence of BPPV and ischemic stroke
in Taiwan.
STUDY DESIGN
We conducted a retrospective cohort study. Patients greater than
20 years of age with a BPPV diagnosis (ICD-9-CM code 386.11)
from January 1, 2000 to December 31, 2008 were selected as the
study cohort. To ensure a correct diagnosis, the patients must have
been diagnosed with BPPV at least twice in the same year accord-
ing to outpatient clinical records or have BPPV as the primary
diagnosis as an inpatient. Patients with a BPPV diagnosis prior
to 2000 were excluded to ensure that only new-onset cases were
examined. Patients with a diagnosis of ischemic stroke prior to the
BPPV diagnosis were also excluded to prevent erroneous causal
relationships. A total of 4104 patients with BPPV were randomly
selected as the study cohort.
Cases in the comparison cohort were randomly selected from
the remaining patients in the database, and their age and gender
were matched with the patients in the study cohort in order to
investigate the relations between BPPV and subsequent ischemic
stroke events. Patients diagnosed with any form of vertigo (ICD-
9-CM code 386) were excluded to prevent the inclusion of cases of
BPPV that were misdiagnosed. Patients diagnosed with ischemic
stroke prior to inclusion were also excluded. A total of 8379
patients were selected as the comparison cohort. In order to evalu-
ate the risk factors of ischemic stroke in elderly people, individuals
aged more than 65 years were extracted from the cohorts for
further analysis (n= 4389).
All the cases were followed up until December 31, 2009 to track
the incidence of ischemic stroke, which was identified by insur-
ance claims. To avoid misdiagnoses, we only enrolled patients
with a primary diagnosis of ischemic stroke (ICD-9-CM code
433–436) as an inpatient. Potential outcome confounders, includ-
ing age, gender, comorbidities [such as hypertension (ICD-9-CM
code 401–405), diabetes mellitus (ICD-9-CM code 250), atrial fib-
rillation/flutter (ICD-9-CM code 427.31, 427.32), coronary artery
disease (ICD-9-CM code 410–414), hyperlipidemia (ICD-9-CM
code 272)], and medications (such as antiplatelets, anticoagulants,
and statins) were considered. Medical comorbidities were defined
as a minimum of two incidences of diagnosis as an outpatient or
a primary diagnosis as an inpatient. Medications prescribed to the
patients at any time during the follow-up period were identified.
STATISTICAL ANALYSIS
Microsoft SQL Server 2005 (Microsoft Corporation) and SPSS
software (SPSS, Inc.) were used for data management and comput-
ing. A Student’s t -test and chi-square tests were conducted to com-
pare the demographic characteristics, medical comorbidities, and
medications of subjects with and without BPPV. Kaplan–Meier
survival analysis was then performed to generate a stroke-free sur-
vival curve. Cox proportional hazard regression was performed to
investigate the independent predictive value of BPPV for stroke
incidence after adjusting for age, gender, hypertension, diabetes
mellitus, atrial fibrillation/flutter, coronary artery disease, hyper-
lipidemia, antiplatelets, anticoagulants, and statins. To determine
the hazard of BPPV with different confounding factors, a strati-
fied analysis of the stroke hazard ratio of BPPV was performed.
Statistical significance was defined as a two-sided p value ≤0.05.
Furthermore, patients more than 65 years old in our study were
extracted and analyzed with chi-square tests to compare the med-
ical comorbidities between those with and without BPPV. Cox
regression analysis was applied to evaluate the risk factors of
ischemic stroke in patients over 65 years of age.
RESULTS
The average ages of the patients in the study and compari-
son cohorts were 57.36± 15.44 and 56.88± 15.55, respectively
(p= 0.113). Because age and gender were matched between
cohorts,no significant differences in age and gender were observed.
Patients with BPPV were more likely to be accompanied by
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Table 1 | Demographic and clinical characteristics comparisons between subjects with and without BPPV (n=12483).
Variables Without BPPV (n=8379) With BPPV (n=4104) pValue
Total N Column% Total N Column%
Age, years (mean±SD) 56.88±15.55 57.36±15.44 0.113
GENDER
Female 5597 66.80 2740 66.80 0.984
Male 2782 33.20 1364 33.20
HTN
No 6134 73.20 2455 59.80 <0.001*
Yes 2245 26.80 1649 40.20
DM
No 7430 88.70 3460 84.30 <0.001*
Yes 949 11.30 644 15.70
AF/AFL
No 8305 99.10 4049 98.70 0.022*
Yes 74 0.90 55 1.30
CAD
No 7542 90.00 3322 80.90 <0.001*
Yes 837 10.00 782 19.10
HYPERLIPIDEMIA
No 7348 87.70 3263 79.50 <0.001*
Yes 1031 12.30 841 20.50
ANTIPLATELET
No 6287 75.03 2427 59.14 <0.001*
Yes 2092 24.97 1677 40.86
ANTICOAGULANTS
No 8327 99.40 4084 99.50 0.38
Yes 52 0.60 20 0.50
STATIN
No 7674 91.60 3532 86.10 <0.001*
Yes 705 8.40 572 13.90
*p<0.05.
HTN, hypertension; DM, diabetes mellitus; Af/AFL, atrial fibrillation/flutter; CAD, coronary artery disease.
hypertension, diabetes mellitus, atrial fibrillation/flutter, coronary
artery disease, and hyperlipidemia; thus, these individuals had a
higher use of antiplatelets, anticoagulants, and statins. The dis-
tributions of demographic characteristics, medical comorbidities,
and medication use between patients with and without BPPV are
shown in Table 1.
A follow-up of each of the 12,483 patients was performed until
the end of 2009 to track the incidence of ischemic stroke. Of the
12,483 patients tracked, a total of 425 patients developed stroke.
Of the 4104 patients with BPPV, 185 (4.5%) developed stroke, and
of the 8379 patients without BPPV, 240 patients (2.9%) devel-
oped stroke. The patients with BPPV were more likely to develop
ischemic stroke than those without BPPV. For BPPV patients, the
crude stroke hazard ratio for developing ischemic stroke was 1.708,
with a confidence interval between 1.409 and 2.069. The stroke-
free survival curve was generated using Kaplan–Meier survival
analysis (Figure 1). After adjustment for age, gender, hyperten-
sion, diabetes mellitus, atrial fibrillation/flutter, hyperlipidemia,
coronary artery disease, and medications (including antiplatelets,
anticoagulants, and statins), the hazard ratio for developing
ischemic strokes during the maximal 9-year follow-up period
was 1.415-fold higher in patients with BPPV than those with-
out BPPV (confidence interval: 1.162–1.723, p= 0.001). Stroke
incidence and the hazard ratios of BPPV are shown in Table 2.
To further estimate the risk of developing ischemic stroke
among individuals with BPPV with different comorbidities, a sub-
group analysis stratified according to age, gender, hypertension,
diabetes mellitus, atrial fibrillation/flutter, coronary artery disease,
and hyperlipidemia was performed. BPPV remained indepen-
dently associated with a higher risk of developing future ischemic
stroke, regardless of age, gender, or the presence of diabetes melli-
tus and hyperlipidemia (Figure 2). The hazard ratio for individuals
under and over 65 years of age were 1.717 and 1.307, respectively;
for females and males were 1.410 and 1.397, respectively.
To determine the risk factors of developing ischemic stroke
specifically among the elderly people, individuals aged over
65 years were extracted from the study and comparison cohorts
(n= 4389). The clinical characteristics of this particular group are
shown in Table 3. Elderly patients with BPPV were more likely to
be comorbid with hypertension, diabetes mellitus, coronary artery
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disease, and hyperlipidemia. Cox regression analysis revealed that
age, male gender, hypertension, diabetes mellitus, and BPPV were
independently associated with increased risk of ischemic stroke
(Table 4). The adjusted hazard ratio of individuals with and
without BPPV is 1.307, indicating that among the elderly pop-
ulation, BPPV patients is at a 1.307-fold higher risk for developing
subsequent ischemic stroke.
DISCUSSION
The main finding of our study was that BPPV was associated
with an increased risk of future ischemic stroke. The association
between BPPV and risk of ischemic stroke remained when consid-
ering underling comorbidities, including diabetes mellitus, hyper-
tension, coronary artery disease, and hyperlipidemia. In our study
population, men over the age of 65 years were more susceptible to
ischemic stroke than women, and BPPV patients in both genders
were associated with increased risk of subsequent ischemic stroke.
FIGURE 1 |The stroke-free survival curve was generated using
Kaplan–Meier survival analysis.
As noted previously, BPPV results from imbalanced semicir-
cular canal nerve stimulation by calcium deposits (Schuknecht,
1969; Hall et al., 1979). Therefore, the causes of BPPV are primar-
ily believed to be mechanical. Because BPPV accounts for 20–30%
of diagnoses in dizziness clinics (Baloh et al., 1989; Neuhauser
et al., 2001) and the BPPV recurrence rate is approximately 12–
20% (Steenerson et al., 2005; Kao et al., 2009), conditions that
are comorbid with BPPV have been rigorously investigated in the
literature. Sunami et al. (2005) reported that BPPV patients with
hypertension and hyperlipidemia are more likely to experience
recurrence. Using a population-based multivariate analysis, von
Brevern’s cross-sectional study showed that age, migraine, hyper-
tension, hyperlipidemia, and stroke were independently associated
with BPPV (von Brevern et al., 2007). These findings are in accor-
dance with our results, which indicated that the prevalence of
hypertension, diabetes mellitus, atrial fibrillation, coronary artery
disease, and hyperlipidemia is higher among patients with BPPV
than among those without BPPV, leading to more frequent pre-
scriptions for antiplatelets and statins in BPPV patients (Table 1).
Age or gender-related factors are the most likely causes of the
linkage between BPPV and ischemic stroke. Cardiovascular risks
increase with age, as do dizziness and vertigo. Dizziness has been
reported in approximately 30% of individuals over 60 years old
(Sloane et al., 1989) and the recurrence rate of BPPV was 1.7-
fold higher in older individuals (Kao et al., 2009). In order to
determine the effects of age and BPPV in future ischemic stroke,
we analyzed the hazard ratio of stroke in the older (≥65 years
old) and younger (<65 years old) populations from our database.
We found that BPPV remained to be associated with subsequent
ischemic strokes in both young and old groups (hazard ratio 1.717
and 1.307, respectively; Figure 2). Despite the fact that BPPV inci-
dence increases with age, the hazard ratio is higher among the
young population in our study, indicating BPPV is indeed related
to future ischemic strokes regardless of age. It is known that men
have a higher incidence of hemorrhagic and ischemic stroke with
the exception between 35 and 44 years of age, and over 85 years
(Goldstein et al., 2011). In our study population, for those who
are≥65 years of age, male gender became an independent predic-
tor for ischemic stroke (hazard ratio= 1.384). Nevertheless, in our
population, BPPV was found to be independently associated with
ischemic stroke in both genders (hazard ratio in female= 1.410,
Table 2 |The incidence and hazard ratio of stroke in subjects with and without BPPV.
Presence of ischemic stroke in maximal
9-year follow-up period
Total subjects Without BPPV With BPPV
Number % Number % Number %
Yes 425 3.4 240 2.9 185 4.5
No 12058 96.6 8139 97.1 3919 95.5
Crude hazard ratio (95% CI) 1 1.708 (1.409 ~ 2.069)**
Adjusted hazard ratio (95% CI) 1 1.415 (1.162 ~ 1.723)*
**p<0.001, *p=0.001.
Adjustment was made for subjects’ age, gender, hypertension, diabetes, atrial fibrillation/flutter, hyperlipidemia, coronary artery disease, and medications including
antiplatelets, coumadin, and statin.
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FIGURE 2 | Hazard ratios (HRs) for BPPV of ischemic stroke development in subgroup analysis.
in male= 1.307; Figure 2). Age and gender-related factors cannot
explain the association of BPPV and formation of ischemic strokes
or other cardiovascular events.
The hypothesis that decreased anterior vestibular artery blood
supply causes BPPV may provide one explanation (Baloh et al.,
1987). Circulation to the inner ear is from the vertebrobasilar
system, primarily the anterior inferior cerebellar artery, which
branches into the anterior vestibular artery. Its anatomical location
within the inner ear makes the labyrinth particularly vulnerable to
ischemia. Wada et al. used carotid ultrasonography to evaluate the
intima–media thickness of the common carotid artery in patients
with BPPV and vestibular hypofunction. This study showed that
the percentage of abnormal intima–media thickness of common
carotid arteries was significantly higher in patients with BPPV
than those with other vestibular disorders (Wada et al., 2008). In
patients with an intima–media thickness greater than 1.1 mm, the
level of residual senses of positional vertigo was higher (Wada
et al., 2009). A study by Zhang et al. (2013) also revealed increased
abnormalities in the vertebrobasilar arteries of BPPV patients. The
severity of vertigo was correlated with vertebral artery stenosis,
occlusion, or tortuosity (Zhang et al., 2013). These reports are
in accordance with our findings (Table 1), which showed that
patients with BPPV had a higher prevalence of hypertension and
coronary artery disease. Blood vessel abnormalities in the BPPV
population, as demonstrated by clinical manifestations and imag-
ing studies, could explain our findings that BPPV patients may be
more susceptible to cardiovascular conditions.
Our retrospective cohort study focused on the subsequent
risk of developing strokes. As shown in Table 2, an increased
risk of stroke (hazard ratio= 1.415) in patients with BPPV was
observed. The higher hazard ratio was still observed even the
adjustment for age, gender, hypertension, diabetes mellitus, atrial
fibrillation/flutter, hyperlipidemia, coronary artery disease, and
medications (including antiplatelets, anticoagulants, and statins).
The diagnosis of BPPV should exclude central nervous system
vertigo (Fife et al., 2008). However, new hypotheses are emerging
regarding whether BPPV is truly benign. One previous retrospec-
tive observational study showed that BPPV patients have increased
vascular risk factors than patients with Ménière’s disease (De
Reuck, 2010). This study indicated that BPPV could progress to
general atherosclerosis. The study by Wada et al. suggested that
patients with vestibular hypofunction may present with slow arte-
riosclerotic changes, likely more frequently in individuals with
BPPV. In our study, we detected a higher prevalence of DM in
the BPPV group. This finding is in agreement with studies by
Cohen et al. (2004) and Yoda et al. (2011). One recent multi-
center observational study found a higher recurrence of BPPV in
patients presenting with hypertension and diabetes mellitus (De
Stefano et al., 2014). Vestibular system vascular damage presenting
with hypertension and diabetes mellitus could lead to higher risks
of future ischemic stroke.
In our study, the subgroup analysis showed a generalized
increased hazard ratio for stroke in BPPV patients with different
comorbidities. These results are in accordance with one previous
observation that vertigo patients with multiple risk factors had
a higher risk of developing stroke (Lee et al., 2011). Our study
demonstrated a specific association between BPPV and ischemic
strokes. Considering underlying atrial fibrillation, an association
between BPPV and ischemic stroke was not observed in our
study population. There are two possible explanations for this
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Table 3 | Clinical characteristics of individuals more than 65-year-old with and without BPPV (n=4389).
Variables Without BPPV (n=2948) With BPPV (n=1441)
Total N Column% Total N Column% pValue
GENDER
Female 1784 60.50 870 60.40 0.948
Male 1164 39.50 571 39.60
HTN
No 1524 51.70 526 36.50 <0.001*
Yes 1424 48.30 915 63.50
DM
No 2396 81.30 1089 75.60 <0.001*
Yes 552 18.70 352 24.40
AF/AFL
No 2881 97.70 1396 96.90 0.103
Yes 67 2.30 45 3.10
CAD
No 2349 79.70 947 65.70 <0.001*
Yes 599 20.30 494 34.30
HYPERLIPIDEMIA
No 2389 81.00 1065 73.90 <0.001*
Yes 559 19.00 376 26.10
*p<0.05.
HTN, hypertension; DM, diabetes mellitus; Af/AFL, atrial fibrillation/flutter; CAD, coronary artery disease.
Table 4 | Predictors of ischemic stroke in individuals more than
65 years old analyzed by Cox regression analysis.
Predictor Hazard
ratio
95% Confidence
interval
pValue
BPPV 1.307 1.037–1.647 0.023*
Age 1.049 1.030–1.068 <0.001*
Male gender 1.384 1.107–1.731 0.004*
HTN 1.318 1.027–1.691 0.03*
DM 1.788 1.383–2.313 <0.001*
Af/AFL 0.96 0.490–1.879 0.905
CAD 1.182 0.915–1.526 0.2
Hyperlipidemia 1.043 0.783–1.389 0.774
*p<0.05.
HTN, hypertension; DM, diabetes mellitus; Af/AFL, atrial fibrillation/flutter; CAD,
coronary artery disease.
observation. First, only 129 subjects with atrial fibrillation were
included in our study; thus, a small sample size may not contain
sufficient information for analysis. A larger sample size including
more individuals with a diagnosis of atrial fibrillation is neces-
sary to investigate the association of BPPV and ischemic stroke
in patients with atrial fibrillation. Another explanation is that
atrial fibrillation itself is the most important risk factor for stroke;
therefore, BPPV may not have played a significant role leading to
ischemic stroke in our patients with atrial fibrillation.
One main value of our study is the utilization of population-
based data. These data allowed us to track the development of
stroke in both cohorts without dropout or loss to follow-up.
Furthermore, the large sample size provided sufficient power for
hazard ratio analyses. However, there are limitations to our study.
First, the diagnosis of stroke and BPPV primarily relied on the
ICD coding recorded in the NHIRD, which may unavoidably lead
to misdiagnoses. To reduce the bias caused by misdiagnoses, we
only included individuals who were diagnosed with BPPV at least
twice in outpatient clinics or had BPPV as the primary diagnosis as
an inpatient. Regarding the diagnosis of stroke, we only included
individuals who were diagnosed with stroke as inpatients because
only those with a diagnosis of stroke can be admitted to hospitals
in Taiwan for intensive care. The same inclusion criteria have been
used in previous retrospective cohort database studies and were
shown to be reliable (Chiang et al., 2011). Second, some important
risk factors, such as tobacco smoking, obesity, dietary habits, and a
sedentary lifestyle, were not available in our database. Investigating
these risk factors is important in future studies. Finally, our data-
base consists primarily of Taiwanese individuals, and our results
may not be applicable to other ethnic groups. However, because
this is the first large retrospective cohort study with East Asian indi-
viduals, it provides important information for East Asian health-
care workers. Once BPPV patients are identified, more aggressive
control of modifiable risk factors, such as blood pressure, blood
sugar, smoking, diet, and exercise, should be suggested to protect
BPPV patients from developing stroke (Goldstein et al., 2011).
CONCLUSION
Patients with BPPV were more susceptible to future ischemic
strokes. Although the mechanisms of this association have yet
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to be identified, clinicians and BPPV patients should be aware
of the likelihood of developing disabling or even life-threatening
vascular events in the future. Large-scale prospective studies are
necessary to provide additional insights into the etiologies of these
two diseases.
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